Home LiteratureArticle Details
PMID: 418906 Published · ppublish fre Comparative Study English Abstract Journal Article

[Preparation and experimental antitumor activity of a new semi-synthetic antibiotic: 14-diethoxyacetoxy daunorubicin (R.P. 33 921)].

Préparation et activité antitumorale expérimentale d'un nouvel antibiotique semi-synthétique : la diéthoxyacétoxy-14 daunorubicine (33 921 R.P,).

Comptes rendus hebdomadaires des seances de l'Academie des sciences. Serie D: Sciences naturelles ·Vol. 286 ·No. 5 ·1978-02-06 ·Pages 443-6

Maral R, Ducep JB, Farge D, Ponsinet G, Reisdorf D

Abstract

14-diethoxyacetoxy daunorubicin (R.P. 33 921) was chosen among a series of new daunorubicin analogues. Its preparation from daunorubicin and its biological activities are described. It displays an antitumoral activity in mice with a better chemotherapeutic index than daunorubicin and doxorubicin.

MeSH Terms
Animals Antibiotics, Antineoplastic Cells, Cultured DNA/biosynthesis Daunorubicin/analogs & derivatives,chemical synthesis,pharmacology Dogs Doxorubicin/pharmacology Mutagens Neoplasms, Experimental/drug therapy Protein Biosynthesis RNA/biosynthesis Rabbits
Chemicals
Antibiotics, Antineoplastic Mutagens RNA Doxorubicin DNA Daunorubicin
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Maral R
Ducep J B
Farge D
Ponsinet G
Reisdorf D
Article Info
Journal
Comptes rendus hebdomadaires des seances de l'Academie des sciences. Serie D: Sciences naturelles
Abbr.
C R Acad Hebd Seances Acad Sci D
Published
1978-02-06
Pages
443-6
Language
fre
Region
France
NLM ID
7501107
Subset
IM
External Links
PubMed source
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com